Clinical Trial Update: Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating oral nicotinamide riboside as a supplement for macula-off retinal detachment is currently recruiting in Australia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Detachment

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Center for Eye Research Australia | Conditions: Retinal Detachment | Phase 4 | Status: RECRUITING